Isomorphic Labs raises $2.1B to scale AI drug design
DeepMind spinout Isomorphic Labs says its drug design engine is repeatable, and investors are funding the long push from partnerships into clinical proof.
Isomorphic Labs News and Analysis
1 verified stories covering Isomorphic Labs, product updates and industry developments.